ÂÜÀòÂÒÂ×

The Research and Development team at Candel Therapeutics is dedicated to advancing oncolytic viral immunotherapies by conducting cutting-edge research and clinical trials. This multidisciplinary group collaborates to design and evaluate novel therapeutic strategies, ensuring the safety and efficacy of treatments through robust clinical data analysis and oversight. Their ultimate goal is to innovate solutions that improve outcomes for cancer patients.